198 related articles for article (PubMed ID: 17910029)
41. Monitoring of human liver and kidney allograft tolerance: a tissue/histopathology perspective.
Demetris AJ; Lunz JG; Randhawa P; Wu T; Nalesnik M; Thomson AW
Transpl Int; 2009 Jan; 22(1):120-41. PubMed ID: 18980624
[TBL] [Abstract][Full Text] [Related]
42. Transcriptome changes in renal allograft protocol biopsies at 3 months precede the onset of interstitial fibrosis/tubular atrophy (IF/TA) at 6 months.
Scherer A; Gwinner W; Mengel M; Kirsch T; Raulf F; Szustakowski JD; Hartmann N; Staedtler F; Engel G; Klupp J; Korn A; Kehren J; Haller H
Nephrol Dial Transplant; 2009 Aug; 24(8):2567-75. PubMed ID: 19398767
[TBL] [Abstract][Full Text] [Related]
43. Impact of endotoxin exposure after exhausting exercise on the immune system in solid organ transplant recipients.
Königsrainer I; Löffler M; Bühler S; Walter M; Schafbuch L; Beckert S; Glatzle J; Horvath P; Northoff H; Nadalin S; Königsrainer A; Zieker D
Exerc Immunol Rev; 2012; 18():177-83. PubMed ID: 22876728
[TBL] [Abstract][Full Text] [Related]
44. Using biomarkers of tolerance and rejection to identify high- and low-risk patients following kidney transplantation.
Ashton-Chess J; Giral M; Soulillou JP; Brouard S
Transplantation; 2009 May; 87(9 Suppl):S95-9. PubMed ID: 19424020
[TBL] [Abstract][Full Text] [Related]
45. Intragraft mRNA cytotoxic molecule expression in renal allograft recipients.
Carstens J; Ozbay A; Tørring C; Hansen HE
Transpl Immunol; 2009 Mar; 20(4):212-7. PubMed ID: 19141320
[TBL] [Abstract][Full Text] [Related]
46. Shared and unique gene expression in systemic lupus erythematosus depending on disease activity.
Sandrin-Garcia P; Junta CM; Fachin AL; Mello SS; Baião AM; Rassi DM; Ferreira MC; Trevisan GL; Sakamoto-Hojo ET; Louzada-Júnior P; Passos GA; Donadi EA
Ann N Y Acad Sci; 2009 Sep; 1173():493-500. PubMed ID: 19758191
[TBL] [Abstract][Full Text] [Related]
47. Long-term follow-up of donor chimerism and tolerance after human liver transplantation.
Ayala R; Grande S; Albizua E; Crooke A; Meneu JC; Moreno A; Pérez B; Gilsanz F; Moreno E; Martínez-Lopez J
Liver Transpl; 2009 Jun; 15(6):581-91. PubMed ID: 19479801
[TBL] [Abstract][Full Text] [Related]
48. Cylex ImmuKnow assay levels are lower in lung transplant recipients with infection.
Bhorade SM; Janata K; Vigneswaran WT; Alex CG; Garrity ER
J Heart Lung Transplant; 2008 Sep; 27(9):990-4. PubMed ID: 18765191
[TBL] [Abstract][Full Text] [Related]
49. A candidate molecular signature associated with tamoxifen failure in primary breast cancer.
Vendrell JA; Robertson KE; Ravel P; Bray SE; Bajard A; Purdie CA; Nguyen C; Hadad SM; Bieche I; Chabaud S; Bachelot T; Thompson AM; Cohen PA
Breast Cancer Res; 2008; 10(5):R88. PubMed ID: 18928543
[TBL] [Abstract][Full Text] [Related]
50. Living donor kidney transplantation across positive crossmatch: the University of Illinois at Chicago experience.
Thielke JJ; West-Thielke PM; Herren HL; Bareato U; Ommert T; Vidanovic V; Campbell-Lee SA; Tzvetanov IG; Sankary HN; Kaplan B; Benedetti E; Oberholzer J
Transplantation; 2009 Jan; 87(2):268-73. PubMed ID: 19155983
[TBL] [Abstract][Full Text] [Related]
51. Selective corticosteroid and calcineurin-inhibitor withdrawal after pancreas-kidney transplantation utilizing thymoglobulin induction and sirolimus maintenance therapy.
Knight RJ; Kerman RH; McKissick E; Lawless A; Podder H; Katz S; Van Buren CT; Kahan BD
Clin Transplant; 2008; 22(5):645-50. PubMed ID: 18657156
[TBL] [Abstract][Full Text] [Related]
52. Quantitative analysis of regulatory T cells in kidney graft recipients: a relationship with calcineurin inhibitor level.
Calvo-Turrubiartes M; Romano-Moreno S; García-Hernández M; Chevaile-Ramos JA; Layseca-Espinosa E; González-Amaro R; Portales-Pérez D
Transpl Immunol; 2009 May; 21(1):43-9. PubMed ID: 19233271
[TBL] [Abstract][Full Text] [Related]
53. Effect of menopause on gene expression profiles of circulating monocytes: a pilot in vivo microarray study.
Dvornyk V; Liu Y; Lu Y; Shen H; Lappe JM; Lei S; Recker RR; Deng H
J Genet Genomics; 2007 Nov; 34(11):974-83. PubMed ID: 18037134
[TBL] [Abstract][Full Text] [Related]
54. Peripheral blood gene expression analysis in intestinal transplantation: a feasibility study for detecting novel candidate biomarkers of graft rejection.
Andreev VP; Tryphonopoulos P; Blomberg BB; Tsinoremas N; Weppler D; Neuman DR; Volsky A; Nishida S; Tekin A; Selvaggi G; Levi DM; Tzakis AG; Ruiz P
Transplantation; 2011 Dec; 92(12):1385-91. PubMed ID: 22183870
[TBL] [Abstract][Full Text] [Related]
55. The immunological monitoring of alloreactive responses in liver transplant recipients: a review.
Reding R; Gras J; Truong DQ; Wieërs G; Latinne D
Liver Transpl; 2006 Mar; 12(3):373-83. PubMed ID: 16498661
[TBL] [Abstract][Full Text] [Related]
56. Sirolimus-based triple immunosupression with antithymocyte globulin induction in expanded criteria donor kidney transplantation.
Uslu A; Nart A; Taşli FA; Postaci H; Aykas A; Doğan M; Sahin T
Nephrology (Carlton); 2008 Feb; 13(1):80-6. PubMed ID: 18199109
[TBL] [Abstract][Full Text] [Related]
57. The combined organ effect: protection against rejection?
Rana A; Robles S; Russo MJ; Halazun KJ; Woodland DC; Witkowski P; Ratner LE; Hardy MA
Ann Surg; 2008 Nov; 248(5):871-9. PubMed ID: 18948817
[TBL] [Abstract][Full Text] [Related]
58. Tolerance assays: measuring the unknown.
Newell KA; Larsen CP
Transplantation; 2006 Jun; 81(11):1503-9. PubMed ID: 16770237
[TBL] [Abstract][Full Text] [Related]
59. The DESCARTES-Nantes survey of kidney transplant recipients displaying clinical operational tolerance identifies 35 new tolerant patients and 34 almost tolerant patients.
Massart A; Pallier A; Pascual J; Viklicky O; Budde K; Spasovski G; Klinger M; Sever MS; Sørensen SS; Hadaya K; Oberbauer R; Dudley C; De Fijter JW; Yussim A; Hazzan M; Wekerle T; Berglund D; De Biase C; Pérez-Sáez MJ; Mühlfeld A; Orlando G; Clemente K; Lai Q; Pisani F; Kandus A; Baas M; Bemelman F; Ponikvar JB; Mazouz H; Stratta P; Subra JF; Villemain F; Hoitsma A; Braun L; Cantarell MC; Colak H; Courtney A; Frasca GM; Howse M; Naesens M; Reischig T; Serón D; Seyahi N; Tugmen C; Alonso Hernandez A; Beňa L; Biancone L; Cuna V; Díaz-Corte C; Dufay A; Gaasbeek A; Garnier A; Gatault P; Gentil Govantes MA; Glowacki F; Gross O; Hurault de Ligny B; Huynh-Do U; Janbon B; Jiménez Del Cerro LA; Keller F; La Manna G; Lauzurica R; Le Monies De Sagazan H; Thaiss F; Legendre C; Martin S; Moal MC; Noël C; Pillebout E; Piredda GB; Puga AR; Sulowicz W; Tuglular S; Prokopova M; Chesneau M; Le Moine A; Guérif P; Soulillou JP; Abramowicz M; Giral M; Racapé J; Maggiore U; Brouard S; Abramowicz D
Nephrol Dial Transplant; 2016 Jun; 31(6):1002-13. PubMed ID: 26763669
[TBL] [Abstract][Full Text] [Related]
60. GATA3 and a dominant regulatory gene expression profile discriminate operational tolerance in human transplantation.
Moraes-Vieira PM; Takenaka MC; Silva HM; Monteiro SM; Agena F; Lemos F; Saitovitch D; Kalil J; Coelho V
Clin Immunol; 2012 Feb; 142(2):117-26. PubMed ID: 22019771
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
